These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6750681)

  • 1. 125I interstitial implants in the RIF-1 murine flank tumor: an animal model for brachytherapy.
    Bernstein M; Gutin PH; Weaver KA; Deen DF; Barcellos MH
    Radiat Res; 1982 Sep; 91(3):624-37. PubMed ID: 6750681
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of a brachytherapy model using 125I in a murine tumor system.
    Jones EL; Lyons BE; Douple EB; Filimonov A; Dain BJ
    Radiat Res; 1989 Apr; 118(1):112-30. PubMed ID: 2704784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combination treatment with cis-platinum and low dose rate 125I radiation in a murine brachytherapy model.
    da Silva V; Gutin PH; Barcellos-Hoff MH; Bernstein MA; Deen DF; Weaver KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1471-2. PubMed ID: 6540767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative biological effectiveness of 125I sources in a murine brachytherapy model.
    Da Silva VF; Gutin PH; Deen DF; Weaver KA
    Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2109-11. PubMed ID: 6490435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basis for the use of enclosed 125I sources for interstitial radiation therapy].
    Volkov AA; Gubareva AV; Gusel'nikov VS; Zaĭtsev VM; Kaganskiĭ VL
    Med Radiol (Mosk); 1985 Aug; 30(8):30-4. PubMed ID: 4033388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD; Adelstein SJ
    Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
    Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
    Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.
    Verhoeff JJ; Stalpers LJ; Coumou AW; Koedooder K; Lavini C; Van Noorden CJ; Haveman J; Vandertop WP; van Furth WR
    Radiat Oncol; 2007 Sep; 2():38. PubMed ID: 17897452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial brachytherapy for intracranial metastases.
    McDermott MW; Cosgrove GR; Larson DA; Sneed PK; Gutin PH
    Neurosurg Clin N Am; 1996 Jul; 7(3):485-95. PubMed ID: 8823776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience with interstitial radiation, interstitial hyperthermia and interstitial photodynamic therapy in a simple animal model.
    Levendag PC; Ruifrok AC; Marijnissen JP; van Putten WL; Visser AG
    Strahlenther Onkol; 1989 Jan; 165(1):56-60. PubMed ID: 2521752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine model for intracellular therapeutic radiation of metastatic melanoma.
    Hill AS; Schneider PD; Chelton KC; Parks NJ
    Curr Surg; 1987; 44(2):132-4. PubMed ID: 3581891
    [No Abstract]   [Full Text] [Related]  

  • 18. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative biologic effectiveness in terms of tumor response of 125I implants compared with 60Co gamma rays.
    Lehnert S; Reniers B; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):224-9. PubMed ID: 16111593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the dose rate constant of the selectSeed 125I interstitial brachytherapy seed.
    Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2006 May; 33(5):1522-3. PubMed ID: 16752586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.